In this episode of the Beyond the Result podcast, Diasorin’s Angelo Rago chats with Nathan Ledeboer, medical director of clinical microbiology and molecular diagnostics at the Medical College of Wisconsin.
Highlights include:
- The shift from a painstakingly slow retrospective analysis to a faster, prospective approach has allowed the clinical laboratory team to advance its diagnostic stewardship efforts and improve testing efficiency in many clinical departments.
- The main difference came from getting buy-in from the system’s executive team, which was looking for cost savings and increased efficiencies after the pandemic. Support from leadership provided access to more resources, such as an analyst who could mine more information from electronic medical records.
- Securing early wins allowed the clinical lab team to generate more excitement about diagnostic stewardship and its potential to improve outcomes while reducing costs. Now, clinicians from a number of departments are working closely with the laboratory to develop decision support tools that will make it easier to order appropriate testing for each situation.
Credits:
Host – Angelo Rago, President of Luminex division of Diasorin
Guest – Nathan Ledeboer, medical director of clinical microbiology and molecular diagnostics at the Medical College of Wisconsin
Producers – Stephanie Ibbotson, Sr. Director of Strategic Marketing and Market Access and Michelle Tabb, PhD, Chief Scientific Officer
Editor – Britta Good, Graphic Designer, Global Marketing
Sign up to be notified for new episodes: https://info.diasorin.com/beyond-the-result-sign-up
https://us.diasorin.com/en/molecular-diagnostics?utm_source=YouTube&utm_medium=YT-description&utm_campaign=Podcast&utm_id=Corporate&utm_term=Ep2
